GEO vs SEO: What B2B SaaS and Health-Tech Founders Need to Know in 2026

Search changed. Most companies haven’t noticed yet.

For most of the last decade, “search” meant Google. You optimized for the algorithm, ranked for keywords, and traffic followed. That model still works — but it’s no longer the whole game.

In 2026, a meaningful and growing percentage of B2B research happens inside AI tools: ChatGPT, Perplexity, Claude, Google’s AI Overviews. When a founder asks “what’s the best ambient documentation tool for clinicians?”, the answer they get isn’t a list of blue links. It’s a synthesized recommendation from the AI — and one or two brands get named. The rest don’t exist in that conversation.

This is what Generative Engine Optimization (GEO) addresses. And for B2B SaaS — especially in health-tech — it’s worth understanding now, before your competitors do.

What GEO actually is (and isn’t)

GEO is the practice of structuring your brand, content, and technical presence so that AI systems can accurately understand what you do, who you serve, and why you’re trustworthy — and therefore cite you when the topic comes up.

It is not:

• A replacement for SEO (Google is still enormous)
• A guaranteed outcome (“rank #1 in ChatGPT” is not a real thing)
• A separate channel you bolt on afterward

It is:

• A set of foundations that make your brand legible to AI systems
• An extension of good SEO, not a replacement
• Front-loaded work (schema, structure, entity clarity) with ongoing monitoring

The foundations overlap heavily with what good technical SEO already requires: semantic HTML, structured data (Schema.org), clean architecture, authoritative content. The difference is in how content is structured and what signals AI systems weight more heavily than traditional search engines do.

What AI systems are actually reading

When an AI model answers a question about your category, it draws on:

1. Training data — your existing content, reviews, documentation, mentions across the web
2. Live retrieval (for tools like Perplexity and GPT-4 with browsing) — what it finds when it fetches your site right now
3. Structured signals — Schema.org markup, entity associations, your llms.txt file

For B2B SaaS, the practical implication: if your product description is inconsistent across your site, your LinkedIn, your G2 profile, and your press mentions, AI systems have a harder time building a coherent entity for your brand. If it’s consistent and well-structured, you become a clear, citable entity for your category.

For health-tech specifically, there’s an added dimension: compliance and trust signals. AI systems processing healthcare-adjacent queries apply extra weight to credibility markers — authoritative authorship, citations, regulatory context. A clinical AI company that publishes authoritative content on its specific domain (even just well-structured FAQs with cited sources) builds a significantly stronger AI-visible presence than one that doesn’t.

The /llms.txt file

One of the simplest and most underused signals: the llms.txt file. Analogous to robots.txt for traditional crawlers, it’s a plain-text file you place at the root of your domain that tells AI systems how to read your site — what content is authoritative, what the brand does, who it serves, and what to prioritize.

Not every AI tool reads it yet. But the ones that support structured inputs increasingly look for it, and it costs nothing to implement. Here’s what a minimal health-tech SaaS llms.txt looks like:

# [Your Company] — Clinical AI SaaS

> [One sentence on what you do]

## What we do
[2-3 sentences on your core product]

## Who we serve
[Target buyer: clinician type, hospital size, geography]

## Authoritative pages
- /: Homepage overview
- /product: Core product description
- /blog: Insight articles on [your domain]

## Contact
[Email or form URL]

If you already have a robots.txt, llms.txt goes in the same folder. Done.

Where to start: the GEO/AEO stack for a B2B SaaS

In priority order, here’s what actually moves the needle for a B2B SaaS or health-tech company in 2026:

1. Schema.org markup — at minimum: Organization, Service, Person (founder), FAQPage. These create machine-readable facts about your brand that AI systems can pull from.

2. Entity consistency — your product name, founder name, company description, and core use case should be identically worded across your site, LinkedIn, Crunchbase, G2/Capterra, and any press coverage. Inconsistency creates ambiguity for AI systems.

3. An authoritative FAQ — a proper FAQ page, marked up as FAQPage schema, covering the questions your buyers actually ask (“What is [your product]?”, “How does [your product] handle [compliance concern]?”, “Who is [your product] for?”). This is the single highest-leverage content investment for AI visibility.

4. Content with a point of view — not keyword-stuffed articles, but content that takes a clear position on a real question in your domain. AI systems learn to associate you with topics you’ve written about clearly and specifically.

5. The llms.txt file — 20 minutes of work, increasingly read by AI tools.

6. Ongoing monitoring — query AI tools directly (“what are the best ambient documentation tools for clinicians?”) on a monthly basis. Track whether and how you appear. Adjust your content and entity signals based on what you find.

The honest answer on outcomes

AI visibility is not a tap you turn on. It’s a set of foundations that make you eligible to be cited — but whether you get cited depends on your category competition, the quality of your content, and the training data of the specific AI system.

What we can tell you is this: the companies building these foundations now will have a measurable edge over those who start in 12 months. The window to be the established, well-cited entity in a specific B2B SaaS or health-tech niche is open. It won’t stay open indefinitely.

---

Bogdan is the founder of UR FTR Inc., an AI-era growth studio that builds GEO/AEO foundations, SEO, and email automation systems for B2B SaaS and health-tech companies. Currently working with DoraScribe and ZoeMD.